Total Payments
$68,503
2024 Payments
$163.22
Companies
11
Transactions
128
Medicare Patients
2,561
Medicare Billing
$238,868
Payment Breakdown by Category
Other$53,678 (78.4%)
Travel$5,682 (8.3%)
Consulting$4,928 (7.2%)
Food & Beverage$3,402 (5.0%)
Education$812.84 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $53,678 | 31 | 78.4% |
| Travel and Lodging | $5,682 | 26 | 8.3% |
| Consulting Fee | $4,928 | 2 | 7.2% |
| Food and Beverage | $3,402 | 45 | 5.0% |
| Education | $812.84 | 24 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $49,848 | 70 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $17,546 | 40 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $337.49 | 3 | $0 (2021) |
| Lilly USA, LLC | $212.50 | 3 | $0 (2018) |
| Amgen Inc. | $135.39 | 4 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $125.00 | 1 | $0 (2017) |
| Abbott Laboratories | $116.42 | 2 | $0 (2020) |
| Insulet Corporation | $94.10 | 1 | $0 (2020) |
| Dexcom, Inc. | $40.61 | 2 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $34.79 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $163.22 | 5 | Amgen Inc. ($135.39) |
| 2022 | $22.84 | 1 | Dexcom, Inc. ($22.84) |
| 2021 | $5,003 | 6 | Novo Nordisk Inc ($4,860) |
| 2020 | $7,224 | 18 | Novo Nordisk Inc ($7,094) |
| 2019 | $18,590 | 25 | Novo Nordisk Inc ($18,590) |
| 2018 | $28,072 | 49 | Novo Nordisk Inc ($19,276) |
| 2017 | $9,428 | 24 | Janssen Pharmaceuticals, Inc ($9,190) |
All Payment Transactions
128 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $115.40 | General |
| Category: Bone Health | ||||||
| 11/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $27.83 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $6.77 | General |
| Category: Bone Health | ||||||
| 10/02/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $7.49 | General |
| Category: Bone Health | ||||||
| 05/29/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $5.73 | General |
| Category: Bone Health | ||||||
| 05/23/2022 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: Endocrinology | ||||||
| 11/12/2021 | Novo Nordisk Inc | Wegovy (Drug) | Consulting Fee | Cash or cash equivalent | $1,215.00 | General |
| Category: Obesity | ||||||
| 09/30/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $688.50 | General |
| Category: Diabetes | ||||||
| 07/27/2021 | DEXCOM, INC. | DEXCOM G6 TRANSMITTER (Device) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/26/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,350.00 | General |
| Category: Diabetes | ||||||
| 06/02/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/15/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,606.50 | General |
| Category: Diabetes | ||||||
| 11/09/2020 | Novo Nordisk Inc | RYBELSUS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,350.00 | General |
| Category: Diabetes | ||||||
| 09/11/2020 | Novo Nordisk Inc | RYBELSUS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,350.00 | General |
| Category: Diabetes | ||||||
| 09/03/2020 | Novo Nordisk Inc | RYBELSUS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $229.50 | General |
| Category: Diabetes | ||||||
| 08/16/2020 | Abbott Laboratories | FreeStyle Libre (Device) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: Diabetes Care | ||||||
| 06/02/2020 | Novo Nordisk Inc | — | Education | In-kind items and services | $32.27 | General |
| 06/02/2020 | Novo Nordisk Inc | — | Education | In-kind items and services | $32.27 | General |
| 06/02/2020 | Novo Nordisk Inc | — | Education | In-kind items and services | $32.27 | General |
| 06/02/2020 | Novo Nordisk Inc | — | Education | In-kind items and services | $32.27 | General |
| 06/02/2020 | Novo Nordisk Inc | — | Education | In-kind items and services | $32.27 | General |
| 06/02/2020 | Novo Nordisk Inc | — | Education | In-kind items and services | $32.27 | General |
| 06/02/2020 | Novo Nordisk Inc | — | Education | In-kind items and services | $32.27 | General |
| 06/02/2020 | Novo Nordisk Inc | — | Education | In-kind items and services | $32.27 | General |
| 06/02/2020 | Novo Nordisk Inc | — | Education | In-kind items and services | $32.27 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 5 | 636 | 965 | $219,236 | $50,705 |
| 2021 | 6 | 881 | 1,642 | $403,147 | $103,901 |
| 2020 | 6 | 1,044 | 1,395 | $299,018 | $84,262 |
Total Patients
2,561
Total Services
4,002
Medicare Billing
$238,868
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 285 | 463 | $172,699 | $40,900 | 23.7% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 251 | 384 | $14,976 | $3,707 | 24.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 46 | 59 | $15,045 | $3,362 | 22.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $10,900 | $1,614 | 14.8% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 34 | 39 | $5,616 | $1,122 | 20.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 347 | 762 | $284,226 | $75,676 | 26.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 119 | 119 | $65,930 | $14,706 | 22.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 61 | 94 | $23,970 | $6,373 | 26.6% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 322 | 631 | $24,609 | $6,122 | 24.9% |
| 95249 | Continuous monitoring of glucose in tissue fluid using sensor under skin | Office | 2021 | 19 | 19 | $2,831 | $854.48 | 30.2% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 13 | 17 | $1,581 | $168.98 | 10.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 409 | 627 | $178,695 | $50,003 | 28.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 166 | 166 | $72,376 | $20,410 | 28.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 85 | 86 | $13,963 | $5,269 | 37.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 61 | 84 | $16,212 | $4,426 | 27.3% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 307 | 411 | $16,029 | $3,962 | 24.7% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 16 | 21 | $1,743 | $192.24 | 11.0% |
About Dr. Nathaniel Clark, MD
Dr. Nathaniel Clark, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Hyannis, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386687234.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nathaniel Clark, MD has received a total of $68,503 in payments from pharmaceutical and medical device companies, with $163.22 received in 2024. These payments were reported across 128 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($53,678).
As a Medicare-enrolled provider, Clark has provided services to 2,561 Medicare beneficiaries, totaling 4,002 services with total Medicare billing of $238,868. Data is available for 3 years (2020–2022), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Hyannis, MA
- Active Since 06/14/2006
- Last Updated 09/27/2012
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1386687234
Products in Payments
- INVOKANA (Drug) $17,665
- Ozempic (Drug) $8,926
- RYBELSUS (Drug) $7,925
- Victoza (Drug) $6,416
- Tresiba (Drug) $5,076
- Wegovy (Drug) $1,215
- FARXIGA (Drug) $337.49
- EVENITY (Biological) $135.39
- FORTEO (Drug) $100.00
- Omnipod (Device) $94.10
- FreeStyle Freedom Lite system (Device) $93.20
- HUMULIN (Drug) $76.55
- JARDIANCE (Drug) $34.79
- FreeStyle Libre (Device) $23.22
- Dexcom G6 Transmitter (Medical Supply) $22.84
- DEXCOM G6 TRANSMITTER (Device) $17.77
- t:slim X2 insulin pump (Device) $12.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Hyannis
Mary Crowell, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $6,302
Endocrinology, Diabetes & Metabolism $6,302
Dr. Catalina Norman, Md, Phd, MD, PHD
Endocrinology, Diabetes & Metabolism — Payments: $2,817
Endocrinology, Diabetes & Metabolism $2,817
Wingyee Wan, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $554.03
Endocrinology, Diabetes & Metabolism $554.03
Doriann Klaassen, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $386.99
Endocrinology, Diabetes & Metabolism $386.99